MicroRNAs: new biomarkers and promising therapeutic targets for diabetic kidney disease

Nascimento, Linicene Rosa do; Domingueti, Caroline Pereira.
J. bras. nefrol; 41(3): 412-422, July-Sept. 2019. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1040242

Documentos relacionados

  1. Urinary miR-3137 and miR-4270 as potential biomarkers for diabetic kidney disease.
  2. Designing stimuli-responsive upconversion nanoparticles based on a mimetic immunoassay for potential accurate diabetic nephropathy diagnosis.
  3. Urinary and Blood MicroRNA-126 and -770 are Potential Noninvasive Biomarker Candidates for Diabetic Nephropathy: a Meta-Analysis.
  4. Association of Elevated Urinary miR-126, miR-155, and miR-29b with Diabetic Kidney Disease.
  5. Urinary biomarkers for early diabetic nephropathy: beyond albuminuria.
  6. Non-invasive metabolic biomarkers for early diagnosis of diabetic nephropathy: Meta-analysis of profiling metabolomics studies.
  7. Determination of certain urinary microRNAs as promising biomarkers in diabetic nephropathy patients using gold nanoparticles.
  8. [Clinico-Pathological Progress in Diabetic Nephropathy].
  9. Urinary exosomes: Potential biomarkers for diabetic nephropathy.
  10. An insight of dysregulation of microRNAs in the pathogenesis of diabetic kidney disease.